Free Trial
→ Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid (From Altimetry) (Ad)tc pixel
NASDAQ:LQDA

Liquidia Q3 2026 Earnings Date & Estimates

Liquidia logo
$26.81 -0.86 (-3.11%)
Closing price 04:00 PM Eastern
Extended Trading
$38.23 +11.42 (+42.61%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Liquidia is estimated to report Q3 2026 earnings on Monday, November 2, 2026, before market opens. The conference call is scheduled for 8:30 AM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
Before Market Opens
Conference Call
8:30 AM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Liquidia in Q3 2026

Liquidia is expected to post earnings of $0.8220 per share on revenue of $201.54 million. In the same quarter a year earlier Liquidia reported -$0.04 per share on revenue of $54.34 million. Liquidia last reported on August 12, 2026, posting $0.74 per share and missing the $0.7580 consensus estimate. Liquidia has beaten the consensus EPS estimate in 4 of its last 8 quarters.

Consensus Estimates

Consensus EPS
$0.8220
Expected Revenue
$201.54 million
Prior-Year EPS
-$0.04
Prior-Year Revenue
$54.34 million
Expected Revenue Growth
+270.9%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
$0.74 (Missed by -$0.0180)
Last Quarter Revenue
$171.68 million
EPS Beat Rate
4 of last 8 quarters

Prepare for the Q3 2026 Call

Liquidia Q3 2026 Earnings FAQ

Liquidia (NASDAQ:LQDA) is estimated to report Q3 2026 earnings on Monday, November 2, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it.

Liquidia's Q3 2026 earnings conference call is scheduled for Monday, November 2, 2026 at 8:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Liquidia to post earnings of $0.8220 per share for Q3 2026.

The consensus revenue estimate for Liquidia is $201.54 million for Q3 2026.

Liquidia Earnings Headlines

Liquidia Corporation and United Therapeutics Reach Global Settlement Resolving All Pending Litigation
 |  quiverquant.comQ
Liquidia Announces Global Settlement Resolving All Pending Litigation with United Therapeutics, Ensuring Continued Commercialization of YUTREPIA in PAH
 |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/10/13/3380250/0/en/liquidia-announces-global-settlement-resolving-all-pending-litigation-with-united-therapeutics-ensuring-continued-commercialization-of-yutrepia-in-pah.html
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.tc pixel
October 13 at 1:00 AM  |  Chaikin Analytics (Ad)
Liquidia Negatively Rated Stock Pick of the Week at Smart Insider Following Chairman's Share Sale
October 13 at 1:53 PM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/liquidia-negatively-rated-stock-pick-133927460.html
Liquidia Corporation (LQDA) Securities Investigation Notice - Levi & Korsinsky
October 12 at 2:55 PM  |  prnewswire.comhttps://www.prnewswire.com/news-releases/liquidia-corporation-lqda-securities-investigation-notice---levi--korsinsky-302905852.html
Liquidia (NASDAQ:LQDA) Shares Gap Up - What's Next?
October 12 at 11:01 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31111111
See More Liquidia Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Liquidia? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Liquidia and other key companies, straight to your email.

About Liquidia

Liquidia (NASDAQ:LQDA) is a biopharmaceutical company focused on developing and commercializing therapies for patients with serious cardiopulmonary diseases and other rare conditions. The company uses its proprietary PRINT technology to engineer drug particles with controlled size, shape and composition, with the goal of improving the delivery and performance of medicines.

Liquidia’s lead product is Yutrepia (treprostinil) inhalation powder, a dry-powder inhaler designed for the treatment of pulmonary arterial hypertension (PAH). Yutrepia was approved by the U.S. Food and Drug Administration in 2025 to improve patients’ ability to perform physical activity. The product was previously known as LIQ861 and is intended to provide a convenient inhaled formulation of treprostinil.

Based in North Carolina’s Research Triangle region, Liquidia primarily serves the U.S. specialty pharmaceutical market and continues to pursue additional applications for its drug-delivery platform. The company’s development strategy is centered on pulmonary vascular diseases, including PAH, where inhaled therapies may offer an alternative to injectable or other treatment options.

View Liquidia Profile
Earnings Tools